Our 2023 Experts Included:
Welcome to the 7th Dermatology Drug Development Summit for Inflammatory Skin Diseases
The Dermatology Drug Development Summit returned for its 7th year as the largest industry focused summit dedicated to advancing treatment options across Atopic Dermatitis, Alopecia Areata, Hidradenitis suppurativa, Prurigo Nodularis and Vitiligo to name a few.
From improving the safety profile of JAK inhibitors to opening the doors to maintenance therapies and cracking the first approved therapies in rare dermatological diseases, these strategic and progressive conversations are not ones to be missed.
This summit provided optimal opportunity to meet with 120+ key opinion leaders from LEO Pharma, AbbVie, Janssen, Sanofi, Almirall, GSK, BMS, Incyte, Dermavant and more to accelerate dermatology pipelines and work towards achieving durable therapies following the success in attaining remittive therapy in Psoriasis.
Our 2023 Speaker Faculty Included:
Subhashis Banerjee
Vice-President, Disease Area Head, Rheumatology and Dermatology
Bristol Myers Squibb
Susan Smith
Executive Director, Inflammation & Autoimmunity & Translational Sciences
Incyte Corporation
2023's Presenting Companies Included:
Testimonials from the Dermatology Drug Development Summit
Our 2023 Partners:
Lead and Hosting Partner